The febrile patient with neutropenia
Cooksley, T.; Holland, M.
Acute Medicine 11(4): 246-250
2012
ISSN/ISBN: 1747-4892 PMID: 23364111 Document Number: 15405
Fever in a neutropenic patient is an acute medical emergency. This article considers the diagnosis, investigation and management of neutropenic sepsis, along with the clinical challenges that an acute physician may face when treating patients presenting with this condition.
Document emailed within 1 workday
Related Documents
Inciardi, J.F. 1994: Empiric therapy for febrile neutropenia Annals of Internal Medicine 121(8): 623-624Rasmy, A.; Al Mashiakhi, M.; Ameen, A. 2017: Chemotherapy-Induced Febrile Neutropenia in Solid Tumours Gulf Journal of Oncology 1(25): 77-84
Takei, N.; Komatsu, T. 2011: Current clinical practice in the treatment of febrile neutropenia (FN) Japanese Journal of Antibiotics 64(5): 293-310
Gupta, S.; Bonilla, M.; Gamero, M.; Fuentes, S.L.; Caniza, M.; Sung, L. 2011: Microbiology and mortality of pediatric febrile neutropenia in El Salvador Journal of Pediatric Hematology/Oncology 33(4): 276-280
Inagaki, M.; Sato, J.; Nihei, S.; Kashiwaba, M.; Kudo, K. 2016: Efficacy of Levofloxacin Hydrate in Febrile Neutropenia for Outpatient Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 593-596
Wakisaka, K.; Tani, S.; Ishibashi, K.; Nukui, K.; Nagao, M. 2015: Results of a post-marketing surveillance of meropenem for febrile neutropenia Japanese Journal of Antibiotics 68(4): 205-224
Nenova, I.S.; Goranov, S.E.; Mateva, N.G.; Ananoshtev, N.H. 2003: Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies Folia Medica 45(1): 13-19
Weerasubpong, B.; Makruasi, N.; Linasmita, P.; Rattanamongkolgul, S. 2016: Factors Associated with Survival Outcomes of Febrile Neutropenia in Hematologic Malignancy Patients Journal of the Medical Association of Thailand 99(Suppl 8): S53-S62
Marr, K.A. 2004: Antifungal therapy for febrile neutropenia: issues in clinical trial design Current Opinion in Investigational Drugs 5(2): 202-207
Sakai, H.; Sanada, M.; Shimamoto, K.; Azuma, R.; Harada, H.; Mori, H.; Niikura, H.; Omine, M. 2007: Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders Japanese Journal of Antibiotics 60(2): 125-131
Pancharoen, C.; Mekmullica, J.; Buranachonapa, J.; Trongjit, D.; Nuchprayoon, I.; Vanichsetakul, P.; Seksarn, P.; Thisyakorn, U. 2003: Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer Journal of the Medical Association of Thailand 86(Suppl 2): S174-S178
Carstensen, M.; Sørensen, J.B. 2008: Outpatient management of febrile neutropenia: time to revise the present treatment strategy Journal of Supportive Oncology 6(5): 199-208
Phikulsod, P.; Suwannawiboon, B.; Chayakulkeeree, M. 2017: Invasive Fungal Infection among Febrile Patients with Chemotherapy-Induced Neutropenia in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 48(1): 159-169
Malik, I.; Shaharyar 2002: Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia JPMA. Journal of the Pakistan Medical Association 52(1): 15-18
Brunner, C.; Botten, J.; Wennike, N.; Ford, L.; Michaels, K.; Stephens, A.; Baker, R. 2019: Early Supported Discharge for patients with febrile neutropenia - Experience at a large district hospital in the UK Acute Medicine 18(1): 14-19
Lai, H-Pao.; Hsueh, P-Ren.; Chen, Y-Chun.; Lee, P-Ing.; Lu, C-Yi.; Lu, M-Yao.; Lin, W-Chuan.; Hsieh, Y-Chia.; Lee, C-Yun.; Lin, K-Hsin.; Huang, L-Min. 2003: Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan Journal of Microbiology Immunology and Infection 36(3): 197-202
Tsuchida, K.; Hayashi, T.; Hayashi, S.; Sawazaki, S.; Jin, Y.; Hasuo, K.; Suzuki, H.; Rino, Y.; Masuda, M. 2010: A case of pseudomembranous colitis with febrile neutropenia induced by chemotherapy and effectively treated by vancomycin enemas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(9): 1821-1823
Karthaus, M.; Meran, J.G.; Geissler, R.G.; Böhme, A.; Jürgens, H.; Ganser, A. 1998: Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia Wiener Medizinische Wochenschrift 148(18): 427-432
Olcay, L.; Dingil, G.ür.üz.; Yildirim, E.; Dilek, G.ül.; Dirim, E. 2007: Splenic abscesses in therapy-resistant acute myeloblastic leukemia presenting as recurrent febrile neutropenia and unresolved splenomegaly Turkish Journal of Pediatrics 49(3): 315-318
Gibson, J.; Johnson, L.; Snowdon, L.; Joshua, D.; Young, G.; MacLeod, C.; Iland, H.; Vincent, P.; Kronenberg, H. 1994: A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases International Journal of Hematology 60(2): 119-127